- Home
- Automated
- NDF A-Z listing
- Insulin Soluble (Human) + Insulin Isophane (Human)
I
Insulin Soluble (Human) + Insulin Isophane (Human)
Subsidy Information and Financing Scheme
SDL
SDL
Drug Guidance
No
Post-marketing information
No
Summary of Biologics
No
Active ingredients: Insulin Soluble | Insulin Isophane | Insulin Soluble (Human) + Insulin Isophane (Human)
General information
Subsidy Information and Financing Scheme
[SDL] Insulin Soluble & Insulin Isophane (Human) (Mixtard) Injection, Insulin Soluble 30% + Insulin Isophane 70% 100 international units/mL
[SDL] Insulin Soluble & Insulin Isophane (Human) (Mixtard) Injection, Penfill, Insulin Soluble 30% + Insulin Isophane 70% 100 international units/mL
Legend
This section shows the following:
Subsidy Scheme and Clinical Indication (where applicable) of drugs listed in the MOH List of Subsidised Drugs
Subsidised brands of vaccines recommended in the National Immunisation Schedules listed in the MOH Subsidised Vaccine List
Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List
As this website is updated monthly, please refer to MOH List of Subsidised Drugs, MOH Subsidised Vaccine List or MediShield Life Cancer Drug List for the most updated information.
Legend list
Indicator | Legend |
|---|---|
SDL | Standard Drug List |
MAF | Medical Assistance Fund |
SVL | Subsidised Vaccine List |
MSHL | Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List |
Drug Guidance for Subsidy
Not Applicable
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Drug availability
Formulation | Public Healthcare Institution |
|---|---|
Mixtard Injection, Insulin Soluble 30% + Insulin Isophane 70% 100 international units/mL |
|
Mixtard Injection, Penfill, Insulin Soluble 30% + Insulin Isophane 70% 100 international units/mL |
|
List of monographs containing this active ingredient
Insulin Soluble (Human) + Insulin Isophane (Human) [Mixtard]